![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Instrumentation Laboratory Introduces HemosIL Apixaban Test
Instrumentation Laboratory Introduces HemosIL Apixaban Test
May 9, 2016
Instrumentation Laboratory has launched its HemosIL Apixaban test in Europe, the company announced Monday, for measuring apixaban, a direct oral anticoagulant for the treatment of venous thromboembolic events.
The test is intended to be used in conjunction with the company’s CE IVD-marked HemosIL apixaban calibrators and controls for precise measurement.
The test joins two other assays in the company’s anticoagulant panel. — Anisa Jibrell
Upcoming Events
-
21Oct